Aroa Biosurgery Limited Email Format
Biotechnology ResearchAuckland, New Zealand201-500 Employees
Aroa Biosurgery Limited is a New Zealand-based biotechnology company focused on soft-tissue regeneration. It develops, manufactures, sells, and distributes medical and surgical products designed to improve healing in complex wounds and during soft tissue reconstruction, based on its proprietary AROA ECM technology derived from ovine forestomach. The company was founded in February 2008 on intellectual property related to forestomach extracellular matrix for tissue regeneration applications. It is headquartered at 64 Richard Pearse Drive, Mangere, Auckland 2022, New Zealand, and employs 201-500 people. The company has engaged in collaborations, including a 2015 partnership with Nasdaq-listed TELA Bio to develop the OviTex product range, and has launched products such as Myriad Morcells in 2021.